Study of FXR0906 in healthy adults with or without high triglycerides
This first-in-human study tests an experimental drug (FXR0906) in healthy adults to see how safe it is and how the body processes it. The drug may one day help lower high triglycerides (fats in the blood).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 55 years old
- Body mass index (BMI) between 18 and 35, with minimum weight of 100–110 pounds depending on sex
- Have a fasting blood level of triglycerides (a type of fat) above 80 mg/dL and LDL (bad cholesterol) above 70 mg/dL
- Be generally healthy, with no significant medical conditions
- Not be taking any cholesterol- or fat-lowering medications in the last 30 days, or certain gene-based lipid drugs in the last year
- Have normal kidney function and liver enzyme levels within acceptable ranges
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called DR10624 to see if it can lower very high levels of triglycerides (a type of fat in the blood) in people who have not been helped enough by standard treatments. The study compares the new drug to a placebo (a dummy shot) over several months.
This early-stage trial tests an investigational drug called ISH0688 to see if it is safe and how well it works in people with high triglycerides (a type of fat in the blood). The study is also checking how the body absorbs and processes the drug.
This study tests a new drug, HRS-7249, to see if it safely lowers high triglyceride levels (a type of fat in the blood) that can increase the risk of heart problems. It is for people who either were in the earlier study of this drug or are new participants with high triglycerides.
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.
This trial tests a new drug called RN5681 to see if it is safe and how the body processes it. It is for healthy people with certain cholesterol levels and may help people with high cholesterol or heart risk in the future.
Hear when a new Healthy Adult Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.